A Jayk Bernal, MM Gomes da Silva… - … Journal of Medicine, 2022 - Mass Medical Soc
… New treatments are needed to reduce the risk of progression of coronavirus disease 2019 (Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active against …
W Wen, C Chen, J Tang, C Wang, M Zhou… - … of medicine, 2022 - Taylor & Francis
… This study shows that three novel oralantiviraldrugs (molnupiravir, fluvoxamine and … rates in COVID-19 patients. In addition, our study showed that the three oralantiviraldrugs did not …
L Tian, Z Pang, M Li, F Lou, X An, S Zhu… - Frontiers in …, 2022 - frontiersin.org
… development stage for treating seasonal influenza. With the spread of COVID-19, the … treatment, and a clinical trial of molnupiravir as an oral therapeutic drug for non-hospitalized …
AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2021 - Elsevier
… Molnupiravir is a newer oralantiviral drug that has recently been tested in COVID-19. We aim to … of literature to find out the efficacy and safety of molnupiravir in patients with COVID-19. …
… candidate therapies for the management of COVID-19. Molnupiravir is an antiviral drug with anti… Molnupiravir is administered orally at doses of 50 mg to 800 mg in each clinical trial. The …
… This study also highlighted that molnupiravir shows antiviral effects because … antiviral efficacy vs. cytotoxicity) and suggested further clinical studies of molnupiravir for influenza treatment…
… Within 3 days of initiating Molnupiraviroraltreatment, the virus load had decreased by an estimated 88%, compared with an expected reduction in untreated cases of 84%. …
E Zarenezhad, M Marzi - Medicinal Chemistry Research, 2022 - Springer
… oralanti-viral drug for the treatment of COVID-19 [4]. The application of this drug on animal species demonstrated the success of molnupiravir … Based on an oralanti-viral ribonucleoside …
GR Painter, MG Natchus, O Cohen, W Holman… - Current opinion in …, 2021 - Elsevier
… in emergency settings where the ability to treat a large number of people quickly may be crucial. … with molnupiravir and what led to its rapid development for the treatment of COVID-19. …